Central nervous system sarcoidosis: Follow-up at MR imaging during steroid therapy

Radiology

Volumn 214, Issue 2, 2000, Pages 411-420

  Dumas, Jean Luc ^a   Valeyre, Dominique ^a   Chapelon Abric, Catherine ^b   Belin, Catherine ^a   Plette, Jean Charles ^b   Tandjaoui Lambiotte, Hamdane ^a   Brauner, Michel ^a   Goldlust, David ^a  

^a AVICENNE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Brain, MR; Sarcoidosis; Skull, MR; Spine, MR; Steroids; Vasculitis

Indexed keywords

PREDNISOLONE 3 SULFOBENZOATE; PREDNISONE ACETATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0033957994     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.214.2.r00fe05411     Document Type: Article

References (44)

1. Newman LS, Rose CS, Maier L. Sarcoidosis. N Engl J Med 1997; 336:1224-1234.
2. Stern BJ, Krumholz A, Johns C, Scott P, Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42:909-917.
3. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157: 1864-1868.
4. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine (Baltimore) 1990; 69:261-276.
5. Agbogu BN, Stern BJ, Sewell C, Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995; 52:875-879.
6. Scott TF. Neurosarcoidosis: progress and clinical aspects. Neurology 1993; 43:8-12.
7. Hayes WS, Sherman JL, Stern BJ, Citrin CM, Pulaski PD. MR and CT evaluation of intracranial sarcoidosis. AJR Am J Roentgenol 1987; 149:1043-1049.
8. Nesbit GM, Miller GM, Baker HL, Ebersold MJ, Scheithauer BW. Spinal cord sarcoidosis: a new finding at MR imaging with Gd-DTPA enhancement. Radiology 1989; 173:839-843.
9. Sherman JL, Stern BJ. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJR Am J Roentgenol 1990; 155: 1293-1301.
10. Seltzer S, Mark AS, Atlas SW. CNS sarcoidosis: evaluation with contrast-enhanced MR imaging. AJR Am J Roentgenol 1992; 158:391-397.
11. Kadakia JK, Collette PM, Sharma OP. Role of magnetic resonance imaging in neurosarcoidosis. Sarcoidosis 1993; 10:98-99.
12. Reed LD, Abbas S, Markivee CR, Fletcher JW. Neurosarcoidosis responding to steroids. AJR Am J Roentgenol 1986; 146:819-821.
13. Lexa FJ, Grossman RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol 1994; 15: 973-982.
14. Smith AS, Meisler DM, Weinstein MA, et al. High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis?. AJR Am J Roentgenol 1989; 153:147-152.
15. Williams DW, Elster AD, Kramer SI. Neurosarcoidosis: gadolinium-enhanced MR imaging. J Comput Assist Tomogr 1990; 14:704-707.
16. Mirfakhraee M, Crofford MJ, Guinto FC, Nauta HJW, Weedn VW. Virchow-Robin space: a path of spread in neurosarcoidosis. Radiology 1986; 158:715-720.
17. Jones EG. On the mode of entry of blood vessels into the cerebral cortex. J Anat 1970; 106:507-520.
18. Powers WJ, Miller EM. Sarcoidosis mimicking glioma: case report and review of intracranial sarcoid mass lesions. Neurology 1981; 31:907-910.
19. Urbach H, Kristof R, Zentner J, Brechtelsbauer D, Solymosi L, Wolf HK. Sarcoidosis presenting as an intra- or extra-axial cranial mass: report of two cases. Neuroradiology 1997; 39:516-519.
20. Pollock H, Hutchings M, Weller RO, Zhang ET. Perivascular spaces in the basal ganglia of the human brain: their relationship to lacunes. J Anat 1997; 191:337-346.
21. Yetkin FZ, Haughton VM, Papke RA, Fischer ME, Rao SM. Multiple sclerosis: specificity of MR for diagnosis. Radiology 1991; 178:447-451.
22. Moody DM, Bell MA, Challa VR. Features of cerebral vascular pattern that predict vulnerability to perfusion or oxygenation deficiency: an anatomic study. AJNR Am J Neuroradiol 1990; 11:431-439.
23. Zhang ET, Inman CBE, Weller RO. Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J Anat 1990; 170:111-123.
24. Ketonen L, Oksanen V, Kuvliala I. Preliminary experience of magnetic resonance imaging in neurosarcoidosis. Neuroradiology 1987; 29:127-129.
25. Miller DH, Kendall BE, Barter S, et al. Magnetic resonance imaging in central nervous system sarcoidosis. Neurology 1988; 38:378-383.
26. Miller DH, Ormerod IEC, Gibson A, du Boulay EP, Rudge P, McDonald WI. MR brain scanning in patients with vasculitis: differentiation from multiple sclerosis. Neuroradiology 1987; 29:226-231.
27. Ylikoski A, Erkinjuntti T, Raininko R, Sarna S, Sulkava R, Tilvis R. White matter hyperintensities on MRI in the neurologically nondiseased elderly: analysis of cohorts of consecutive subjects aged 55 to 85 years living at home. Stroke 1995; 26:1171-1177.
28. Salonen O, Autti T, Raininko R, Ylikoski A, Erkinjuntti T. MRI of the brain in neurologically healthy middle-aged and elderly individuals. Neuroradiology 1997; 39:537-545.
29. Meltzer CC, Fukui MB, Kanal E, Smirniotopoulos JG. MR imaging of the meninges. I. Normal anatomic features and nonneoplastic disease. Radiology 1996; 201:297-308.
30. Caplan L, Corbett J, Goodwin J, Thomas C, Shenker D, Schatz N. Neuro-ophthalmologic signs in the angiitic form of neurosarcoidosis. Neurology 1983; 33:1130-1135.
31. Meyer JS, Foley JM, Campagna-Pinto D. Granulomatous angiitis of the meninges in sarcoidosis. Arch Neurol Psychiatry 1953; 69:587-600.
32. Brown MM, Thompson AJ, Wedzicha JA, Swash M. Sarcoidosis presenting with stroke. Stroke 1989; 20:400-405.
33. Greenan TJ, Grossman RI, Goldberg HI. Cerebral vasculitis: MR imaging and angiographic correlation. Radiology 1992; 182:65-72.
34. Hutchings M, Weller RO. Anatomical relationships of the pia mater to cerebral blood vessels in man. J Neurosurg 1986; 65:316-325.
35. Harris KG, Tran DD, Sickels WJ, Cornell SH, Yuh WTC. Diagnosing intracranial vasculitis: the roles of MR and angiography. AJNR Am J Neuroradiol 1994; 15:317-330.
36. Negishi C, Sze G. Vasculitis presenting as primary leptomeningeal enhancement with minimal parenchymal findings. AJNR Am J Neuroradiol 1993; 14:26-28.
37. Ina Y, Takada K, Yamamoto M, Sato T, Ito S, Sato S. Antiphospholipid antibodies: a prognostic factor in sarcoidosis. Chest 1994; 105: 1179-1183.
38. Provenzale JM, Heinz ER, Ortel TL, Macik BG, Charles LA, Alberts MJ. Antiphospholipid antibodies in patients without systemic lupus erythematosus: neuroradiologic findings. Radiology 1994; 192:531-537.
39. Provenzale JM, Barboriak DP, Allen NB, Ortel TL. Patients with antiphospholipid antibodies: CT and MR findings of the brain. AJR Am J Roentgenol 1996; 167:1573-1578.
40. Geissler A, Andus T, Roth M, et al. Focal white-matter lesions in brain of patients with inflammatory bowel disease. Lancet 1995; 345:897-898.
41. Sage MR, Wilson AL. The blood-brain barrier: an important concept in neuroimaging. AJNR Am J Neuroradiol 1994; 15:601-622.
42. Frequin ST, Barkhof F, Lamers KJ, Hommes OR. The effects of high-dose methylprednisolone on gadolinium-enhanced magnetic resonance imaging and cerebrospinal fluid measurements in multiple sclerosis. J Neuroimmunol 1992; 40:265-272.
43. Brauner MW, Lenoir S, Grenier P, Cluzel P, Battesti JP, Valeyre D. Pulmonary sarcoidosis: CT assessment of lesion reversibility. Radiology 1992; 182:349-354.
44. Manz HJ. Pathobiology of neurosarcoidosis and clinicopathologic correlation. Can J Neurol Sci 1983; 10:50-55.